アポリポ蛋白M/スフィンゴシン-1-リン酸によるインスリン抵抗性の予防
Bibliographic Information
- Other Title
-
- アポ リポタンパク M/スフィンゴシン-1-リンサン ニ ヨル インスリン テイコウセイ ノ ヨボウ
- Protection Against Insulin Resistance by Apolipoprotein M/Sphingosine-1-Phosphate
Search this article
Abstract
<jats:p>Subjects with low serum HDL cholesterol levels are reported to be susceptible to diabetes, with insulin resistance believed to be the underlying pathological mechanism. Apolipoprotein M (apoM) is a carrier of sphingosine-1-phosphate (S1P), a multifunctional lipid mediator, on HDL, and the pleiotropic effects of HDL are believed to be mediated by S1P. In the current study, we attempted to investigate the potential association between apoM/S1P and insulin resistance. We observed that the serum levels of apoM were lower in patients with type 2 diabetes and that they were negatively correlated with BMI and the insulin resistance index. While deletion of apoM in mice was associated with worsening of insulin resistance, overexpression of apoM was associated with improvement of insulin resistance. Presumably, apoM/S1P exerts its protective effect against insulin resistance by activating insulin signaling pathways, such as the AKT and AMPK pathways, and also by improving the mitochondrial functions through upregulation of SIRT1 protein levels. These actions of apoM/S1P appear to be mediated via activation of S1P1 and/or S1P3. These results suggest that apoM/S1P exerts protective roles against the development of insulin resistance.</jats:p>
Journal
-
- Diabetes : a journal of the American Diabetes Association
-
Diabetes : a journal of the American Diabetes Association 14 (1), 14-25, 2020-12
Tokyo : Blackwell Publishing